Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Study Results
Related Studies
Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
This study has been completed.
Study NCT00364858 Information provided by Genzyme
First Received: August 15, 2006 Last Updated: September 3, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gaucher Disease, Type 1
Cerebroside Lipidosis Syndrome
Additional conditions recognized in this trial
Deficiency Diseases
Gaucher Disease
Lipidoses
Syndrome
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Disease
Genetic Diseases, Inborn
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Lymphatic Diseases
Lysosomal Storage Diseases
Lysosomal Storage Diseases, Nervous System
Malnutrition
Metabolic Diseases
Metabolism, Inborn Errors
Nervous System Diseases
Nutrition Disorders
Pathologic Processes
Reticuloendotheliosis
Sphingolipidoses
Interventions listed in this trial
Cerezyme
Sponsors listed in this trial
Genzyme
Back to top of Main Content
